Instant COVID-19 sensor to protect communities

9 July 2021 by IdeaSpies

COVID-19

An instant COVID-19 sensor made in Australia could help transform day-to-day management of the pandemic, protecting frontline workers and the wider community.

RMIT is collaborating with partners including Melbourne-based biomedical start-up Soterius on the biosensor, which can detect the presence of tiny amounts of the SARS-CoV-2 virus and its variants.

Reliable, accurate and non-invasive, the Soterius Scout sensor can deliver results within a minute to provide the all-clear for someone to enter their work environment or alert them if they need to undertake a medical COVID test and self-isolate.

https://www.rmit.edu.au/news/all-news/2021/jul/instant-covid-sensor

What do you think?

You must be logged in to post a comment.

Comments

Sailesh Pudasaini @ 2021.08.14 1:18 PM
This will be very good idea for us being protected from the viruses like Covid-19. Love the concept.

Aashish @ 2021.08.14 1:18 PM
This is great.

Amir gharti @ 2021.08.20 12:23 PM
Reliable idea for this bored pandemic ,and great help to detect the virus,really great idea.

Related Posts

COVID-19

siRNA for Treatment of SARS-CoV-2

RNA interference in animals involves small double-stranded RNA molecules called siRNA. These molecules are valuable tools for studying single gene function in both in vivo and in vitro settings and are also considered a promising class of therapeutics. SiRNA delivery systems fall into two categories: viral and non-viral, including peptides, polymers, and lipids. Studies using synthetic or plasmid-encoded siRNA show its antiviral effects against various viruses, including SARS-CoV. Learn more about siRNA for Treatment of SARS-CoV-2: https://sars-cov-2.creative-biolabs.com/sirna-for-the-treatment-of-sars-cov2.htm

27 September 2023 by Creative Biol... 0 Comments

COVID-19

Vaccine factories in shipping containers

BioNTech, which co-developed a revolutionary mRNA covid-19 vaccine in partnership with Pfizer, hopes to revolutionise another area of pharmaceuticals: vaccine manufacturing. It is developing vaccine factories to sit inside a series of standard metal shipping containers, which it plans to send to parts of the world that lack their own vaccine-manufacturing capabilities-notably Africa. Each facility, BioNTech says, will be able to produce up to 60m doses of covid vaccines and other vaccines each year, and will cost "significantly less" than conventional factories. If so, this could be the future of drugmaking. https://www.economist.com/science-and-technology/biontech-plans-to-make-vaccines-in-shipping-containers/

18 February 2022 by IdeaSpies 0 Comments